Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
Stock Information for PLUS THERAPEUTICS Inc.
Loading
Please wait while we load your information from QuoteMedia.